CVS Health Corporate Other — Operating Income increased by 121.6% to $4.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.7%, from $3.37B to $4.68B. Over 4 years (FY 2021 to FY 2025), Corporate Other — Operating Income shows a downward trend with a -23.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
A smaller loss or higher income indicates better management of corporate overhead and more efficient allocation of resources.
This metric measures the operating profit or loss generated by the corporate segment after accounting for all associated...
Comparable to corporate segment operating income or unallocated corporate profit/loss in large diversified conglomerates.
cvs_segment_corporate_other_operating_income_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.33B | $3.06B | $2.35B | $3.55B | $4.67B | -$3.92B | $3.66B | $3.45B | $3.23B | $3.69B | $3.37B | $2.27B | $3.05B | $832.00M | $2.37B | $3.37B | $2.38B | -$3.21B | $2.11B | $4.68B |
| QoQ Change | — | -29.2% | -23.4% | +51.1% | +31.7% | -183.9% | +193.4% | -5.8% | -6.2% | +14.1% | -8.6% | -32.7% | +34.1% | -72.7% | +184.6% | +42.5% | -29.4% | -234.7% | +165.9% | +121.6% |
| YoY Change | — | — | — | — | +7.9% | -228.0% | +56.0% | -2.8% | -30.7% | +194.2% | -7.8% | -34.1% | -5.8% | -77.5% | -29.8% | +48.6% | -21.8% | -485.5% | -10.8% | +38.7% |